Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityActive in the last 2 years

Maimon E. Hubbi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9763-287X; OpenAlex author ID A5003600685. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. The HIF-2 transcription factor mediates resistance to ferroptosis in pancreatic cancer. Co-author DOI 10.1016/j.molcel.2026.03.007↗
  2. Bcl-xL Enforces a Slow-Cycling State Necessary for Survival in the Nutrient-Deprived Microenvironment of Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-22-0431↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Alexander Muir · 2 shared papers, 2022–2026 · strength 0.41
  2. Ben Z. Stanger · 2 shared papers, 2022–2026 · strength 0.41
  3. Chi Van Dang · 2 shared papers, 2022–2026 · strength 0.41
  4. Erin Elizabeth Hollander · 1 shared paper, 2026 · strength 0.29
  5. Salina Yuan · 1 shared paper, 2022 · strength 0.13
  6. Robert J. Norgard · 1 shared paper, 2022 · strength 0.13
  7. Colin S. Sheehan · 1 shared paper, 2022 · strength 0.13
  8. Ian A. Blair · 1 shared paper, 2022 · strength 0.13
  9. Yogev Sela · 1 shared paper, 2022 · strength 0.13
  10. Jinyang Li · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.